- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-32-0004459

Ocelot Pharma Private Limited
About Ocelot Pharma Private Limited
Data last updated:
Ocelot Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 17 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24304KA2018PTC109622. Its GSTIN is 29AACCO6322N1Z2 (Karnataka). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pankaj Kumar Tripathi and Arun Kumar Verma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at V Srinivasa # 156/6 – 12 3rd Main Jakkasandra, Bangalore, Karnataka, India – 560034.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.17 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹1.46 Lakh (net margin 67.2%) and EBITDA of ₹1.46 Lakh (EBITDA margin 67.2%).
Ocelot Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-32-0004459).
Company details
Recognitions & Rankings of Ocelot Pharma
Contact details
Ocelot Pharma Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressV Srinivasa # 156/6 – 12 3rd Main Jakkasandra, Bangalore, Karnataka, India – 560034
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Ocelot Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ocelot Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Ocelot Pharma Private Limited, buy the company report.
Financials of Ocelot Pharma Private Limited
FY 2025 filings availableOcelot Pharma Private Limited reported revenue of ₹2.17 Lakh (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 9% in the latest year. EBITDA rose 212% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.46 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.46 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 67.2% | ||||
| Net Profit Margin | 67.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ocelot Pharma Private Limited, buy the company report.
Board of directors of Ocelot Pharma Private Limited
Ocelot Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Kumar Tripathi | Director | 17 Jan 2018 | 8 Years 10 Months | Current |
| Arun Kumar Verma Also directs: Rayzoe Retail Private Limited | Director | 17 Jan 2018 | 8 Years 10 Months | Current |
Peer comparison
Ocelot Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vukkadala Chemicals Private Limited | ₹2.26 Lakh (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Sushenah Skin and Health Care Private Limited | ₹2.26 Lakh (FY 2025) | 3.0% | Bangalore, Karnataka, India | |||
| Vimson Paints and Chemicals Private Limited | ₹2.25 Lakh (FY 2025) | -16.0% | Thane, Maharashtra, India | |||
| S R M (India) Limited | ₹2.22 Lakh (FY 2024) | -99.0% | New Delhi, Delhi, India | |||
| MGN Pharma Private Limited | ₹2.22 Lakh (FY 2025) | 50.0% | Delhi, India | |||
| Ocelot Pharma Private Limitedthis company | ₹2.17 Lakh (FY 2025) | ₹1.46 Lakh | 67.2% | 9.0% | Bangalore, Karnataka, India | |
| Transene Electronic Chemicals India Private Limited | ₹2.16 Lakh (FY 2025) | 21543.0% | Bangalore, Karnataka, India | |||
| Cyanotec Bio-Products Private Limited | ₹2.1 Lakh (FY 2025) | 24.0% | Bangalore, Karnataka, India | |||
| Vision Sights Private Limited | ₹1.93 Lakh (FY 2025) | Chennai, Tamil Nadu, India | ||||
| Chemzn Private Limited | ₹1.84 Lakh (FY 2025) | Mumbai, Maharashtra, India | ||||
| Airmid Lifesciences Private Limited | ₹1.82 Lakh (FY 2025) | -37.0% | Pune, Maharashtra, India |
To see the full peer comparison of Ocelot Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ocelot Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ocelot Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ocelot Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCO6322N1Z2 | Karnataka | Active | 29 Oct 2018 |
| 09AACCO6322N1Z4 | Uttar Pradesh | Active | 30 Jan 2019 |
To see the full GST registrations and return filing status of Ocelot Pharma Private Limited, buy the company report.
Recent activity
Ocelot Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Arun Kumar Verma was appointed as Director on 17 Jan 2018.
Frequently asked questions
Ocelot Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 17 January 2018 (8+ years old) and is registered under CIN U24304KA2018PTC109622.
Ocelot Pharma has 2 current directors:
- Pankaj Kumar Tripathi - Director
- Arun Kumar Verma - Director
The latest financial statements of Ocelot Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Ocelot Pharma is 29AACCO6322N1Z2, registered in Karnataka. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AACCO6322N1Z4 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Ocelot Pharma is U24304KA2018PTC109622. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ocelot Pharma was incorporated on 17 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Ocelot Pharma by revenue are Vukkadala Chemicals Private Limited, Sushenah Skin and Health Care Private Limited, Vimson Paints and Chemicals Private Limited, S R M (India) Limited, MGN Pharma Private Limited and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).
Arun Kumar Verma was appointed as Director on 17 Jan 2018. Pankaj Kumar Tripathi was appointed as Director on 17 Jan 2018.
Yes, Ocelot Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-32-0004459).
The registered office of Ocelot Pharma is at V Srinivasa # 1566 – 12 3rd Main Jakkasandra, Bangalore, Karnataka, India – 560034.
Ocelot Pharma operates in the food and beverages industry, in the manufacturing segment.

